Better Coronavirus Stock: VBI Vaccines or Vaxart?
Vaxart (NASDAQ: VXRT) and VBI Vaccines (NASDAQ: VBIV) are both young vaccine companies seeking to develop a vaccine for COVID-19. Neither company is profitable, but both stocks have experienced triple-digit growth in the last three months. Future stock growth stemming from advances in vaccine development is highly likely, even if neither company manages to move its vaccine candidate all the way through clinical trials to reach commercialization.
Given that both companies have a credible chance at developing a winning COVID-19 vaccine, which company is the better stock for smart biotech investors, and why?
Image source: Getty Images.
Source Fool.com
